rs67967266
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002156.5(HSPD1):c.551A>G(p.Asn184Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000546 in 1,613,192 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002156.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 13Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hypomyelinating leukodystrophy 4Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HSPD1 | NM_002156.5 | c.551A>G | p.Asn184Ser | missense_variant | Exon 5 of 12 | ENST00000388968.8 | NP_002147.2 | |
| HSPD1 | NM_199440.2 | c.551A>G | p.Asn184Ser | missense_variant | Exon 5 of 12 | NP_955472.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000328 AC: 50AN: 152240Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000469 AC: 118AN: 251386 AF XY: 0.000500 show subpopulations
GnomAD4 exome AF: 0.000568 AC: 830AN: 1460952Hom.: 2 Cov.: 29 AF XY: 0.000561 AC XY: 408AN XY: 726862 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000328 AC: 50AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74380 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia Uncertain:2
- -
- -
Spastic paraplegia Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 184 of the HSPD1 protein (p.Asn184Ser). This variant is present in population databases (rs67967266, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of hereditary spastic paraplegia (PMID: 28832565). ClinVar contains an entry for this variant (Variation ID: 424666). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt HSPD1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect HSPD1 function (PMID: 27630992). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at